Highlights
- •This is the first report of Susac Syndrome and ischemic colitis.
- •Common pathophysiological mechanisms are proposed.
- •The possibility of escalation of immunosuppressive treatment might be analyzed.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic and PersonalSubscribe:
Subscribe to Journal of the Neurological SciencesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Aggressive immunosuppressive treatment of Susac's syndrome in an adolescent: using treatment of dermatomyositis as a model.Pediatr. Rheumatol. Online J. 2008; 6: 3
- The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis.Hum. Pathol. 1996; 27: 1
- Characteristics of Susac syndrome: a review of all reported cases.Nat. Rev. Neurol. 2013; 9: 307-316
- Diagnostic criteria for Susac syndrome.J. Neurol. Neurosurg. Psychiatry. 2016; (jnnp-2016-314295)
- Brain histopathology in three cases of Susac's syndrome: implications for lesion pathogenesis and treatment.J. Neurol. Neurosurg. Psychiatry. 2014; (jnnp-2014-308240)
- Ischemic colitis.Clin. Colon Rectal Surg. 2015; 28: 093-098
- Novel gastrointestinal tract manifestations in juvenile dermatomyositis.J. Pediatr. 1999; 135: 371-374
- Case report: severe central nervous system involvement in juvenile dermatomyositis.J. Rheumatol. 2003; 30: 2059-2063
- Retinopathy of dermatomyositis.J. Clin. Neuroophthalmol. 1985; 5: 177-179
- Retinocochleocerebral vasculopathy.Medicine (Baltimore). 1998; 77: 12-40
Article Info
Publication History
Published online: June 26, 2017
Accepted:
June 25,
2017
Received in revised form:
June 23,
2017
Received:
April 7,
2017
Identification
Copyright
© 2017 Elsevier B.V. All rights reserved.
